|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-10-23
|
|
pubmed:abstractText |
Vitiligo is an acquired depigmenting disease with uncertain aetiopathogenesis, possibly associated with oxidative stress. Narrowband ultraviolet B phototherapy (NB-UVB) is the most widely used and effective treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0307-6938
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
32
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
631-6
|
|
pubmed:meshHeading |
pubmed-meshheading:17953631-Adult,
pubmed-meshheading:17953631-Antioxidants,
pubmed-meshheading:17953631-Ascorbic Acid,
pubmed-meshheading:17953631-Combined Modality Therapy,
pubmed-meshheading:17953631-Double-Blind Method,
pubmed-meshheading:17953631-Drug Combinations,
pubmed-meshheading:17953631-Female,
pubmed-meshheading:17953631-Humans,
pubmed-meshheading:17953631-Male,
pubmed-meshheading:17953631-Middle Aged,
pubmed-meshheading:17953631-Oxidation-Reduction,
pubmed-meshheading:17953631-Severity of Illness Index,
pubmed-meshheading:17953631-Skin Pigmentation,
pubmed-meshheading:17953631-Thioctic Acid,
pubmed-meshheading:17953631-Treatment Outcome,
pubmed-meshheading:17953631-Ultraviolet Therapy,
pubmed-meshheading:17953631-Vitamin D,
pubmed-meshheading:17953631-Vitiligo
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.
|
|
pubmed:affiliation |
San Gallicano Dermatological Institute, IRCCS, Rome, Italy.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study
|
